| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017281929 |
| P356 | DOI | 10.1007/S00441-014-1876-Y |
| P698 | PubMed publication ID | 24816987 |
| P50 | author | Theresa Ahrens | Q59691607 |
| P2093 | author name string | Martin Werner | |
| Silke Lassmann | |||
| P2860 | cites work | CDX1 is an important molecular mediator of Barrett's metaplasia | Q24529062 |
| A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma | Q33529283 | ||
| Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples. | Q33755701 | ||
| Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis | Q33869648 | ||
| MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival | Q34102917 | ||
| Linking cell signaling and the epigenetic machinery | Q34143422 | ||
| The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis | Q34149750 | ||
| MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer | Q34268637 | ||
| Oesophageal carcinoma | Q34325751 | ||
| Epigenetic alteration and microRNA dysregulation in cancer | Q34392645 | ||
| 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | Q34770609 | ||
| Overexpression of DNA damage-induced 45 α gene contributes to esophageal squamous cell cancer by promoter hypomethylation | Q35998526 | ||
| MicroRNA expression profiles of esophageal cancer | Q36490960 | ||
| MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma | Q36717252 | ||
| A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
| HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses | Q37073624 | ||
| Esophageal adenocarcinoma arising in Barrett esophagus | Q37169303 | ||
| Protein alterations in ESCC and clinical implications: a review | Q37194843 | ||
| Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 | Q37330745 | ||
| Review of the alterations in DNA methylation in esophageal squamous cell carcinoma | Q38071897 | ||
| MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer | Q38095501 | ||
| Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. | Q38116602 | ||
| Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells. | Q38318992 | ||
| Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway | Q38477901 | ||
| MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma | Q39179399 | ||
| MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor | Q39495719 | ||
| Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer | Q39550203 | ||
| Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers | Q39704207 | ||
| Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer | Q40126734 | ||
| Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells | Q40325608 | ||
| Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas | Q43168396 | ||
| LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma | Q45166931 | ||
| IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma | Q45895946 | ||
| Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus | Q46294277 | ||
| Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. | Q53257500 | ||
| LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. | Q54302136 | ||
| P433 | issue | 3 | |
| P921 | main subject | epigenetics | Q26939 |
| P304 | page(s) | 643-655 | |
| P577 | publication date | 2014-05-10 | |
| P1433 | published in | Cell and Tissue Research | Q1524113 |
| P1476 | title | Epigenetics in esophageal cancers | |
| P478 | volume | 356 |
| Q55000594 | ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. |
| Q50174149 | Colorimetric and electrochemical quantification of global DNA methylation using a methyl cytosine-specific antibody. |
| Q36464436 | Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma |
| Q26751209 | Emerging therapeutic targets in esophageal adenocarcinoma |
| Q40978666 | Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia |
| Q37702670 | NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population |
| Q33598672 | Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma |
| Q26786210 | Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma |
| Q38809883 | Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity |
| Q49229820 | Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance |
| Q38881033 | Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine |
| Q26750641 | The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma |
| Q37726416 | mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes |
Search more.